Juno赞助的临床试验
总计263个结果
-
Seung-Jung ParkCardioVascular Research Foundation, Korea招聘中
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkCardioVascular Research Foundation, Korea撤销
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Fred Hutchinson Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb Company终止难治性 B 细胞非霍奇金淋巴瘤 | 复发性成人急性淋巴细胞白血病 | 复发性 B 细胞非霍奇金淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 难治性成人急性淋巴细胞白血病 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 复发性转化非霍奇金淋巴瘤 | 伴有 MYC、BCL2 和 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 具有 MYC、BCL2 和 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性 B 型急性淋巴细胞白血病 | 复发性弥漫性大 B 细胞淋巴瘤,未另行说明 | 伴有 MYC 和 BCL2 或 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 难治性... 及其他条件美国
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb Company主动,不招人
-
Seung-Jung ParkCardioVascular Research Foundation, Korea终止
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Seung-Jung Park完全的
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkCardioVascular Research Foundation, Korea招聘中
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Jun-Won Chung完全的Helicobacter Infected Patients大韩民国
-
Seung-Jung ParkAbbott; CardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkAbbott; CardioVascular Research Foundation, Korea完全的
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Bristol-Myers Squibb Services Unlimited Company招聘中
-
Seung-Jung ParkDio; CardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkAbbott; CardioVascular Research Foundation, Korea完全的
-
Seung-Jung ParkAbbott; CardioVascular Research Foundation, Korea终止